Drugpatentwatch: Annual Sales • Drug Prices • Investigational Drugs • Patents • Litigation
Business intelligence on pharmaceutical and biologic drugs - life cycle management, brand erosion, generic entry, biosimilars, 505(b)(2), patents, sales, litigation, and more...
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-02 | 26.52 |
| 2025-03 | 22.374 |
| 2025-04 | 30.311 |
| Source | Traffic Share |
|---|---|
| search | 57.50% |
| direct | 33.48% |
| referrals | 5.52% |
| social | 2.46% |
| paid referrals | 0.86% |
| 0.11% |
| Region | Percentage |
|---|---|
| United States | 56.21% |
| India | 6.38% |
| United Kingdom | 4.56% |
| KR | 3.47% |
| VN | 3.11% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| lumigan 0.01 olombia | 0 | 0 | $0.00 |
| how long has jublia been available | 0 | 0 | $0.00 |
| how much does it cost to change the shape of pills for a company | 7 | 70 | $0.00 |
| dupi lost of exclusivity | 3 | 30 | $0.00 |
| is polysorbate 80 added to ivermectin | 0 | 0 | $0.00 |